During the second edition of this newly expanded one day program, an invitation-only group of entrepreneurs, executives and investors will be talking about innovation in diagnostics…opportunities in China…next-generation sequencing and computation technology…and the interface between drug and device makers and the consumer.
Speakers include James Heywood, Co-Founder, PatientsLikeMe; John Mendlein PhD, Executive Chairman, Fate Therapeutics; Eric Schadt PhD, CSO, Pacific Biosciences; and Thomas Daniel MD, President of Global Research, Cellgene. It’ll be a day full of data points, deep insight, new connections, and conversation.
Additional information can be found at http://www.convergenceforum.com/agendawest.html or request an invitation at http://www.convergenceforum.com/inv_req.html.